The DEEP project has received research funding from the European Union under the 7th Framework Programme

deep-3

7th DEEP General Assembly meeting in Padua (Italy)

marzo 25, 2016
|
Comments off
|

After the sad decision to cancel the General Assembly Meeting in Tunis, due to the disorders which have occurred across the country, the 7th DEEP General Assembly (GA) will take place in Padua (Italy) on April 13th -15th, 2016 with the participation of the whole DEEP […]

Share
Read more →

DEEP-3 at a glance: interview to Prof. Antje Neubert

marzo 25, 2016
|
Comments off
|

DEEP-3 is a long-term observational safety study which evaluates the nature and incidence of adverse effects of deferiprone (DFP) in children and adolescents with beta-thalassaemia major by conducting a multi-centre, multi-national, observational cohort study with both retrospective (using chart review) and prospective data […]

Share
Read more →

DEEP-3: an update on the observational study

ottobre 30, 2015
|
Comments off
|

DEEP-3 is a long-term observational safety study which evaluates the nature and incidence of adverse effects of deferiprone (DFP) in children and adolescents with beta-thalassaemia major and currently involves 18 recruiting centres from 7 different countries: Albania, Cyprus, Greece, Egypt, Italia, Morocco and Tunisia.

On […]

Share
Read more →